Patient Note — 247653

progress_notes_247653_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID247653 (PHI redacted)
Age / Gender57 / Male
Date of Service2026-04-20
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - Fair Oaks
PayerAetna
Reason1. Path review

Diagnoses

C61 Prostate cancer

Medications

Meloxicam Concerta(Methylphenidate HCl ER (OSM)) FLUoxetine HCl PROzac Medication List reviewed and reconciled with the patient

Past Medical History

  • Anxiety
  • Depression
  • ADHD
  • Elevated PSA
  • High Cholesterol
  • Obstructive Sleep Apnea (CPAP)
  • anxiety: Yes
  • arthritis: Yes
  • thyroid disease: Yes
  • Progress Note: [PROVIDER_NAME], MD 04/20/2026
  • Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
  • Generated for Printing/Faxing/eTransmitting on: 04/21/2026 02:42 PM EDT
  • 1/3
  • 4/21/26, 11:42 AM Print Preview
  • [PATIENT_NAME] DOB: [DOB] (57 yo M) Acc No. [ACCOUNT_ID] DOS: 04/20/2026

Vitals

RR 16.0
HR 1.0
BP 1
BMI 29.41
WEIGHT 185 lbs
HEIGHT_IN 66.5

Clinical Summary (HPI)

General Urology: 57 yM with Hx of elevated PSA presents today for path review. He is doing well s/p TP MRI fusion PNBx (04/2026) without ER visits or hospatalization. ----------------- Prior work-up: TP MRI fusion PNBx (04/2026): P3 lesion >1cm R PZPL at base. Path: Prostatic adenocarcinoma, Gleason 3+4=7 lesion 1B (100%) 1C (70%) 1A (60%), LPM#1 (90%), R PZ wing#1 (90%), RPL#1 (70%), RPM#1 (60%), LPM#2 (60%), RA#1 TZ (50%), RPM#2 (50%), R PZ wing#2 (20%), L A#1 TZ (20%). Gleason 3+3=6 LPL#2 (20%) (reviewed and interpreted) pMRI (01/2026): Prostate Vol 27g. PIRADS 3- Some focal decreased T2 signal noted R posterior bailar and mid gland peripheral zone, abuts prostatic capsule. PSAD 0.3 (reviewed and interpreted) UAmicro: Neg. UCx: Mixed flora (01/2026) Labs (11/2025): Chol 209, HDL 39, LDL 153, HbA1c 5.7, TSH 0.32, PSA (11/2025): 8.35.

Raw Note (de-identified preview)

4/21/26, 11:42 AM Print Preview [PATIENT_NAME] DOB: [DOB] (57 yo M) Acc No. [ACCOUNT_ID] DOS: 04/20/2026 [PATIENT_NAME] 57 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS], [ADDRESS]-[ZIP] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Aetna PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Fair Oaks 04/20/2026 Prostate bx fu: [PROVIDER_NAME], MD Reason for Appointment 1. Path review History of Present Illness General Urology: 57 yM with Hx of elevated PSA presents today for path review. He is doing well s/p TP MRI fusion PNBx (04/2026) without ER visits or hospatalization. ----------------- Prior work-up: TP MRI fusion PNBx (04/2026): P3 lesion >1cm R PZPL at base. Path: Prostatic adenocarcinoma, Gleason 3+4=7 lesion 1B (100%) 1C (70%) 1A (60%), LPM#1 (90%), R PZ wing#1 (90%), RPL#1 (70%), RPM#1 (60%), LPM#2 (60%), RA#1 TZ (50%), RPM#2 (50%), R PZ wing#2 (20%), L A#1 TZ (20%). Gleason 3+3=6 LPL#2 (20%) (reviewed and interpreted) pMRI (01/2026): Prostate Vol 27g. PIRADS 3- Some focal decreased T2 signal noted R posterior bailar and mid gland peripheral zone, abuts prostatic capsule. PSAD 0.3 (reviewed and interpreted) UAmicro: Neg. UCx: Mixed flora (01/2026) Labs (11/2025): Chol 209, HDL 39, LDL 153, HbA1c 5.7, TSH 0.32, PSA (11/2025): 8.35. Current Medications Taking Meloxicam 15 MG Tablet Oral Concerta(Methylphenidate HCl ER (OSM)) 18 MG Tablet Extended Release 1 tablet in the morning Orally Once a day FLUoxetine HCl 20 MG Capsule Oral Not-Taking PROzac 10 MG Capsule 1 capsule Orally Once a day , Notes to Pharmacist: 20 mg Medication List reviewed and reconciled with the patient Past Medical History Anxiety. Depression. ADHD. Elevated PSA. High Cholesterol. Obstructive Sleep Apnea (CPAP). anxiety: Yes. arthritis: Yes. thyroid disease: Yes. Progress Note: [PROVIDER_NAME], MD 04/20/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/21/2026 02:42 PM EDT 1/3 4/21/26, 11:42 AM Print Preview [PATIENT_NAME] DOB: [DOB] (57 yo M) Acc No. [ACCOUNT_ID] DOS: 04/20/2026 Surgical History Prostate Bx 2026 Family History Father: Cardiac Social History Recreational drug use: No. Exercise: Yes. Caffeine: Yes. Alcohol Yes. Sexually active: Yes. Occupation: Yes. Tobacco Control (Standard) Tobacco use: Current smoker Screening Allergies N.K.D.A. Hospitalization/Major Diagnostic Procedure No Hospitalization History. Review of Systems 11 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the patient cdw. Vital Signs RR: 16, HR: 1, BP: 1 mm Hg, Ht: 66.5, Wt: 185 lbs, BMI: 29.41 Index. Assessments 1.Prostate cancer - C61 Treatment 1.Prostate cancer IMAGING: PET : PSMA Pylarify for Prostate Cancer Notes: PSA (11/2025): 8.35 pMRI (01/2026): Prostate Vol 27g. PIRADS 3- Some focal decreased T2 signal noted R posterior base and mid gland peripheral zone, abuts prostatic capsule.